Skip to content

Advertisement

Articles

Sort by
Page 1 of 2
  1. Content type: Debate

    After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an expert report presented recommendations, which focused on vulnerable groups including people who inject drugs (PWID). Th...

    Authors: Jean-Michel Delile, Victor de Ledinghen, Marie Jauffret-Roustide, Perrine Roux, Brigitte Reiller, Juliette Foucher and Daniel Dhumeaux

    Citation: Hepatology, Medicine and Policy 2018 3:7

    Published on:

  2. Content type: Research

    In the United States, the highest burden of chronic hepatitis B (CHB) and CHB-related liver cancer is in the state of California, primarily in the San Francisco (SF) Bay and Los Angeles (LA) areas. The aim of ...

    Authors: Mehlika Toy, Bin Wei, Tejpal S. Virdi, An Le, Huy Trinh, Jiayi Li, Jian Zhang, Ann W. Hsing, Samuel K. So and Mindie H. Nguyen

    Citation: Hepatology, Medicine and Policy 2018 3:6

    Published on:

  3. Content type: Research

    Many persons infected with Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in the past are now lost to follow-up. The aim of the Northern Holland Hepatitis Retrieval Project (NHHRP) is to retrieve and re-e...

    Authors: N. Beekmans and M. Klemt-Kropp

    Citation: Hepatology, Medicine and Policy 2018 3:5

    Published on:

  4. Content type: Research

    Hepatic encephalopathy (HE) is one of the most important severe complications of liver cirrhosis. Thought to be caused by elevated blood levels of gut-derived neurotoxins (particularly ammonia) entering the br...

    Authors: Aleksander Krag, Marcus Schuchmann, Hanna Sodatonou, Jeff Pilot, James Whitehouse, Simone I. Strasser and Mark Hudson

    Citation: Hepatology, Medicine and Policy 2018 3:4

    Published on:

  5. Content type: Research

    WHO hepatitis B guidelines recommend testing all new HIV patients, treating them accordingly or providing immunization. At the Infectious Diseases Institute (IDI) following an audit done in 2012, only 46% pati...

    Authors: Musomba Rachel, Castelnuovo Barbara, Claire Murphy, Charlene Komujuni, Patience Nyakato, Ponsiano Ocama, Mohammed Lamorde, Philippa Easterbrook and Rosalind Parkes Ratanshi

    Citation: Hepatology, Medicine and Policy 2018 3:3

    Published on:

  6. Content type: Research

    The current model of care for the treatment of chronic hepatitis B (CHB) in Australia is through specialist Hepatology or Infectious Diseases clinics, and limited accredited primary care practices. Capacity is...

    Authors: Debra A. O’Leary, Eleanor Cropp, David Isaac, Paul V. Desmond, Sally Bell, Tin Nguyen, Darren Wong, Jessica Howell, Jacqui Richmond, Jenny O’Neill and Alexander J. Thompson

    Citation: Hepatology, Medicine and Policy 2018 3:1

    Published on:

  7. Content type: Review

    The 16 countries of the Eastern Europe and Central Asia (EECA) region are home to 6.6 million people in need of treatment for chronic hepatitis C virus (HCV) infection. Because of transformational change in HC...

    Authors: Ludmila Maistat, Natalija Kravchenko and Amulya Reddy

    Citation: Hepatology, Medicine and Policy 2017 2:9

    Published on:

  8. Content type: Research

    India is home to one in 14 of all chronic hepatitis B virus (HBV) cases, meaning that it is important to develop HBV interventions that are applicable in the Indian context. Vaccination is the foremost tool fo...

    Authors: Gourdas Choudhuri, Rajesh Ojha, T. S. Negi, Varun Gupta, Shipra Saxena, Arundhati Choudhuri, Sanjoy Pal, Jui Choudhuri and Alok Sangam

    Citation: Hepatology, Medicine and Policy 2017 2:10

    Published on:

  9. Content type: Debate

    The International AIDS Society convened the 3rd International HIV/Viral Hepatitis Co-Infection Meeting on 17 July 2016 as part of the pre-conference program preceding the 21st International AIDS Conference hel...

    Authors: Tongai G. Maponga, Rachel Matteau Matsha, Sébastien Morin, Andrew Scheibe, Tracy Swan, Isabelle Andrieux-Meyer, C. Wendy Spearman, Marina B. Klein and Jürgen Kurt Rockstroh

    Citation: Hepatology, Medicine and Policy 2017 2:8

    Published on:

  10. Content type: Research

    Comprehensive information on the incidence and duration of hepatitis C virus (HCV) infection for people who inject drugs (PWID) in Ireland is not available. We created an incidence curve of injecting drug use ...

    Authors: Anne Marie Carew, Niamh Murphy, Jean Long, Kate Hunter, Suzi Lyons, Cathal Walsh and Lelia Thornton

    Citation: Hepatology, Medicine and Policy 2017 2:7

    Published on:

  11. Content type: Roundtable discussion

    Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been screened yet and are unaware of their infections; an...

    Authors: David FitzSimons, Greet Hendrickx, Johannes Hallauer, Heidi Larson, Daniel Lavanchy, Ina Lodewyckx, Daniel Shouval, John Ward and Pierre Van Damme

    Citation: Hepatology, Medicine and Policy 2016 1:16

    Published on:

  12. Content type: Debate

    The treatment of hepatitis C has entered a new era since the advent of curative pharmaceuticals. As policy, government and civil society assemble in response, there are still gaps to be addressed. The Manifest...

    Authors: Eberhard Schatz, Katrin Schiffer, Mags Maher, Magdalena Harris, Xavier Major Roca, Mojca Maticic and Astrid Leicht

    Citation: Hepatology, Medicine and Policy 2016 1:14

    Published on:

  13. Content type: Research

    The human immunodeficiency virus (HIV) epidemic in Russia, driven by injection drug use, has seen a steady rise in the past two decades. Hepatitis C virus (HCV) infection is highly prevalent in people who inje...

    Authors: Judith I. Tsui, Stephen C. Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E. Chaisson, Natalia Gnatienko and Jeffrey H. Samet

    Citation: Hepatology, Medicine and Policy 2016 1:13

    Published on:

  14. Content type: Debate

    The inaugural World Hepatitis Summit was jointly convened by the World Health Organization (WHO) and the World Hepatitis Alliance and hosted by the Scottish Government and supported by Glasgow Caledonian Unive...

    Authors: Charles Gore, Stefan Wiktor, David Goldberg, Sharon Hutchinson, Jose Antonio Oñate Moreno and Raquel Peck

    Citation: Hepatology, Medicine and Policy 2016 1:12

    Published on:

  15. Content type: Research

    People who inject drugs (PWID) are disproportionately affected by both HIV and hepatitis C infection (HCV). Awareness of infection status is essential to ensure linkage to appropriate healthcare for those infe...

    Authors: Stine Nielsen, Martyna Gassowski, Benjamin Wenz, Norbert Bannert, Claus-Thomas Bock, Claudia Kücherer, R. Stefan Ross, Viviane Bremer, Ulrich Marcus and Ruth Zimmermann

    Citation: Hepatology, Medicine and Policy 2016 1:8

    Published on:

  16. Content type: Research

    HCV/HIV coinfection in people who inject drugs is a public health issue, which presents a variety of challenges to healthcare providers. The determinants of HCV/HIV coinfection in this population are nonethele...

    Authors: Anastasios Fotiou, Eleftheria Kanavou, Argyro Antaraki, Clive Richardson, Manina Terzidou and Anna Kokkevi

    Citation: Hepatology, Medicine and Policy 2016 1:9

    Published on:

  17. Content type: Research

    HIV co-infection exacerbates hepatitis C disease, increasing the risk of cirrhosis and hepatitis C-related mortality. Combination antiretroviral therapy (cART) is the current standard treatment for co-infected...

    Authors: Alexis Llewellyn, Mark Simmonds, Will L Irving, Ginny Brunton and Amanda J Sowden

    Citation: Hepatology, Medicine and Policy 2016 1:10

    Published on:

  18. Content type: Research

    India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India lim...

    Authors: Partha Sarathi Mukherjee, Eliza Dutta, Dipesh Kr. Das, Shatabdi Ghosh, Suvadip Neogi and Arka Sarkar

    Citation: Hepatology, Medicine and Policy 2016 2:6

    Published on:

  19. Content type: Editorial

    World Hepatitis Day 2016 marks one year since Hepatology, Medicine and Policy (HMAP) began accepting submissions. There have been many major developments in the fight against hepatitis B virus (HBV) and hepatitis...

    Authors: Jeffrey V. Lazarus, Kelly Safreed-Harmon and Mojca Maticic

    Citation: Hepatology, Medicine and Policy 2016 2:4

    Published on:

  20. Content type: Review

    Wilson’s disease is an inherited disorder in which defective biliary excretion of copper leads to its accumulation, particularly in the liver and brain. Mutations in the ATP7B gene on chromosome 13 cause Wilso...

    Authors: Francisco Hevia-Urrutia, Ileana Alvarado-Echeverría, Alfredo Sanabria-Castro, Marta Sánchez-Molina, Luis Meza-Sierra, Alexander Parajeles-Vindas, Oscar Méndez-Blanca, Álvaro Sánchez-Siles, Manuel Saborío-Rocafort, Marcela Barguil-Gallardo, Iliana Chavarría-Quirós and Cecilia Monge-Bonilla

    Citation: Hepatology, Medicine and Policy 2016 2:5

    Published on:

  21. Content type: Research

    Hepatitis B and C are major public health threats in the World Health Organization (WHO) European Region. Viral hepatitis surveillance shortcomings have resulted in many WHO Member States having insufficient d...

    Authors: Jeffrey V. Lazarus, Antons Mozalevskis, Kelly Safreed-Harmon and Irina Eramova

    Citation: Hepatology, Medicine and Policy 2016 1:3

    Published on:

Page 1 of 2